Jupiter Topco LLC Takes $8.76 Million Position in Cigna Group $CI

Jupiter Topco LLC purchased a new stake in Cigna Group (NYSE:CIFree Report) during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund purchased 31,762 shares of the health services provider’s stock, valued at approximately $8,755,000.

Other large investors have also recently bought and sold shares of the company. EFG International AG acquired a new stake in Cigna Group in the second quarter valued at $2,491,000. Ancora Advisors LLC purchased a new position in shares of Cigna Group in the 2nd quarter valued at about $115,000. Canada Pension Plan Investment Board acquired a new stake in shares of Cigna Group in the second quarter valued at about $148,809,000. Lakewood Capital Management LP acquired a new stake in shares of Cigna Group in the second quarter valued at about $117,938,000. Finally, Legal & General Group Plc purchased a new stake in Cigna Group during the second quarter worth about $542,779,000. Hedge funds and other institutional investors own 86.99% of the company’s stock.

Cigna Group Stock Performance

Shares of CI opened at $278.89 on Monday. The company has a current ratio of 0.76, a quick ratio of 0.76 and a debt-to-equity ratio of 0.68. The stock has a market cap of $73.69 billion, a P/E ratio of 11.54, a PEG ratio of 0.96 and a beta of 0.29. The company has a 50-day moving average of $283.52 and a two-hundred day moving average of $281.30. Cigna Group has a 12-month low of $239.51 and a 12-month high of $315.47.

Cigna Group (NYSE:CIGet Free Report) last released its quarterly earnings results on Thursday, July 30th. The health services provider reported $7.78 EPS for the quarter, beating the consensus estimate of $7.60 by $0.18. Cigna Group had a net margin of 2.27% and a return on equity of 19.75%. The business had revenue of $70.04 billion for the quarter, compared to analyst estimates of $70.14 billion. During the same period in the prior year, the business earned $7.20 earnings per share. The company’s quarterly revenue was up 6.7% on a year-over-year basis. Cigna Group has set its FY 2026 guidance at 30.450- EPS. As a group, research analysts predict that Cigna Group will post 30.51 EPS for the current fiscal year.

Cigna Group Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Wednesday, September 23rd. Shareholders of record on Tuesday, September 8th will be given a dividend of $1.56 per share. The ex-dividend date of this dividend is Tuesday, September 8th. This represents a $6.24 annualized dividend and a yield of 2.2%. Cigna Group’s dividend payout ratio (DPR) is presently 25.82%.

Analysts Set New Price Targets

A number of brokerages have issued reports on CI. Wall Street Zen raised shares of Cigna Group from a “hold” rating to a “buy” rating in a report on Saturday. The Goldman Sachs Group boosted their price target on Cigna Group from $335.00 to $340.00 and gave the stock a “buy” rating in a research note on Monday, May 4th. Deutsche Bank Aktiengesellschaft cut Cigna Group from a “buy” rating to a “hold” rating and lowered their price target for the stock from $303.00 to $302.00 in a report on Wednesday, May 20th. Wells Fargo & Company raised their price objective on Cigna Group from $305.00 to $307.00 and gave the company an “equal weight” rating in a research note on Friday, July 31st. Finally, Mizuho lifted their price objective on Cigna Group from $330.00 to $340.00 and gave the stock an “outperform” rating in a report on Monday, June 8th. Fifteen equities research analysts have rated the stock with a Buy rating and seven have given a Hold rating to the company’s stock. Based on data from MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus price target of $339.45.

Check Out Our Latest Research Report on Cigna Group

Insiders Place Their Bets

In other news, insider Nicole S. Jones sold 19,436 shares of the company’s stock in a transaction on Tuesday, August 4th. The stock was sold at an average price of $276.27, for a total value of $5,369,583.72. Following the sale, the insider directly owned 27,256 shares in the company, valued at $7,530,015.12. This represents a 41.63% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CAO Jamie G. Kates sold 899 shares of the stock in a transaction on Friday, June 12th. The shares were sold at an average price of $298.61, for a total value of $268,450.39. Following the sale, the chief accounting officer directly owned 2,368 shares in the company, valued at approximately $707,108.48. The trade was a 27.52% decrease in their position. The disclosure for this sale is available in the SEC filing. Over the last three months, insiders sold 23,012 shares of company stock valued at $6,386,550. Insiders own 0.60% of the company’s stock.

Cigna Group Company Profile

(Free Report)

Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.

In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.

Further Reading

Want to see what other hedge funds are holding CI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cigna Group (NYSE:CIFree Report).

Institutional Ownership by Quarter for Cigna Group (NYSE:CI)

Receive News & Ratings for Cigna Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cigna Group and related companies with MarketBeat.com's FREE daily email newsletter.